쎌바이오텍 사업보고서 (2015.12)
1. 요약재무정보

가. 요약연결재무정보

구 분	제 21기	제 20기	제 19기

(2015년12월말)	(2014년12월말)	(2013년12월말)

[유동자산]	54,150,513,012	38,800,498,113	28,341,029,572

·현금및현금성자산	7,272,875,829	5,385,808,119	4,759,941,648

·매출채권및기타유동채권	9,311,574,554	8,354,572,007	4,887,192,251

·금융상품자산	34,606,184,587	22,138,811,666	15,802,535,666

·단기투자자산	-	308,852,595	-

·재고자산	2,521,478,081	1,985,857,841	2,521,855,194

·기타유동자산	438,399,961	626,595,885	369,504,813

[비유동자산]	20,817,336,026	18,803,634,418	18,357,122,803

·장기매출채권및기타비유동채권	264,874,621	226,520,721	235,207,672

·금융상품자산	505,000,000	506,000,000	506,000,000

·장기투자증권	287,043,173	488,062,169	357,837,250

·유형자산	18,780,486,861	16,769,895,823	16,455,542,264

·무형자산	843,148,796	679,982,615	655,892,460

·이연법인세자산	136,782,575	133,173,090	146,643,157

자 산 총 계	74,967,849,038	57,604,132,531	46,698,152,375

[유동부채]	6,163,135,072	5,206,116,240	3,610,152,402

[비유동부채]	47,462,020	37,462,020	37,462,020

부 채 총 계	6,210,597,092	5,243,578,260	3,647,614,422

[지배기업 소유주지분]	68,757,251,946	52,360,554,271	43,050,537,953

[자본금]	4,700,000,000	4,700,000,000	4,700,000,000

[자본잉여금]	12,759,754,094	12,759,754,094	12,759,754,094

[자본조정]	(5,260,426,445)	(5,260,426,445)	(5,260,426,445)

[기타포괄손익누계액]	48,368,033	(1,189,378)	(66,510,212)

[이익잉여금]	56,509,556,264	40,162,416,000	30,917,720,516

[비지배지분]	-	-	-

자 본 총 계	68,757,251,946	52,360,554,271	43,050,537,953

기 간	(2015.01.01~	(2014.01.01~	(2013.01.01~

2015.12.31)	2014.12.31)	2013.12.31)

매출액	49,504,515,603	40,767,743,986	31,597,823,868

영업이익	18,758,807,947	12,905,528,179	9,391,588,356

당기순이익	17,505,140,264	10,402,695,484	7,799,753,916

지배기업 소유주지분	17,505,140,264	10,402,695,484	7,799,753,916

비지배지분	-	-	-

주당순이익	2,268	1,347	1,010

연결에포함된회사수	3	3	3

나.요약별도재무정보

구 분	제 21기	제 20기	제 19기

(2015년12월말)	(2014년12월말)	(2013년12월말)

[유동자산]	53,860,925,500	38,348,055,313	27,857,424,588

·현금및현금성자산	6,822,021,385	4,924,776,918	4,380,331,970

·매출채권및기타유동채권	10,418,352,866	9,337,826,816	5,739,029,259

·금융상품자산	33,706,184,587	21,238,811,666	14,902,535,666

·단기투자자산	-	308,852,595	-

·재고자산	2,488,101,480	1,936,220,896	2,496,590,083

·기타유동자산	426,265,182	601,566,422	338,937,610

[비유동자산]	22,233,829,427	20,442,417,308	19,024,889,472

·장기매출채권및기타비유동채권	8,850,411	8,850,411	204,070,411

·금융상품자산	505,000,000	506,000,000	506,000,000

·장기투자증권	224,009,929	461,164,833	357,837,250

·종속기업투자주식	2,118,819,740	2,065,845,531	870,854,187

·유형자산	18,616,137,994	16,701,018,122	16,363,921,863

·무형자산	689,416,428	644,222,381	610,621,026

·이연법인세자산	71,594,925	55,316,030	111,584,735

자 산 총 계	76,094,754,927	58,790,472,621	46,882,314,060

[유동부채]	5,415,695,302	4,263,932,125	3,227,540,382

[비유동부채]	47,677,600	37,677,600	37,677,600

부 채 총 계	5,463,372,902	4,301,609,725	3,265,217,982

[자본금]	4,700,000,000	4,700,000,000	4,700,000,000

[자본잉여금]	12,759,754,094	12,759,754,094	12,759,754,094

[자본조정]	(5,260,426,445)	(5,260,426,445)	(5,260,426,445)

[기타포괄손익누계액]	(3,298,882)	26,926,508	31,506,505

[이익잉여금]	58,435,353,258	42,262,608,739	31,386,261,924

자 본 총 계	70,631,382,025	54,488,862,896	43,617,096,078

종속ㆍ관계ㆍ공동기업 투자주식의 평가방법	원가법	원가법	원가법

기 간	(2015.01.01~	(2014.01.01~	(2013.01.01~

2015.12.31)	2014.12.31)	2013.12.31)

매출액	49,024,773,708	40,461,684,447	31,409,550,330

영업이익	19,214,527,103	14,616,719,951	10,505,018,936

당기순이익	17,330,744,519	12,034,346,815	8,993,126,187

주당순이익	2,245	1,559	1,165